Mylan

"United against COVID-19" will support projects that assist vulnerable groups affected by the crisis, including medical staff, people with disabilities, the elderly, children, minorities, the homeless, the unemployed, single parents and others, the US Embassy in Bulgaria reported.

Israeli pharmaceutical giant Teva said on July 27 that it was buying the generic drug business of Allergan for $40.5 billion, consolidating its position as a world leader in generics.

Teva will pay $33.75 billion in cash and offer $6.75 billion of its stock to Allergan, the company said, in a major move that will further shake up the industry.